The Treatment of Advanced Gastric Cancer: In Search of the Right Combination
- 14 July 2000
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (14) , 2645-2647
- https://doi.org/10.1200/jco.2000.18.14.2645
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive ChemotherapyOncology, 1995
- Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of Clinical Oncology, 1991
- Ergebnisse eines modifizierten FAMeth-Chemotherapieprotokolls beim metastasierten MagenkarzinomDeutsche Medizinische Wochenschrift (1946), 1989
- Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.Journal of Clinical Oncology, 1986
- Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1985
- A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric CarcinomaJAMA, 1985
- Cisplatin.An active drug in the treatment of disseminated gastric cancerCancer, 1984
- Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancerAmerican Journal of Clinical Oncology, 1983
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- Integration of chemotherapy into combined modality treatment of solid tumors: III. Gastric cancerCancer Treatment Reviews, 1974